Dr. Martin Viciano Gofferje

Partner | Rechtsanwalt
Handelsblatt / Best Lawyers in Germany 2021/2022
"Recommended for venture capital law"

Dr. Martin Viciano Gofferje

Partner | Rechtsanwalt
Handelsblatt / Best Lawyers in Germany 2021/2022
"Recommended for venture capital law"
Expertise
Expertise

Martin's practice areas are M&A, private equity, venture capital and corporate law. This includes advising clients in complex national and cross-border M&A transactions and joint ventures. He heads the Gleiss Lutz sector group Healthcare and Life Science and is Gleiss Lutz country relationship partner for the Iberian Peninsula and Latin America. Martin is also the firm's diversity representative.

Vita
Martin studied at the universities of Freiburg and Alicante. He has been a partner at Gleiss Lutz since 2017. In 2010/2011 he worked as a foreign attorney at leading international law firms in Madrid, Barcelona, New York and London.

He speaks German, English and Spanish.
Fields
Fields
CorporateCapital MarketsMergers and AcquisitionsPrivate EquityHealthcare and Life SciencesTMTDigital EconomyDigital Future
Mandates
Mandates
06.12.2021
Gleiss Lutz advises medical devices manufacturer Integer on its acquisition of Oscor
More
10.11.2021
Gleiss Lutz advises Coloplast on the acquisition of Atos Medical
More
21.10.2021
Gleiss Lutz advises US investor Measure 8 Ventures on financing round for Frankfurt startup Bloomwell Group
More
19.10.2021
Gleiss Lutz advises ASML on the sale of Berliner Glas Medical and SwissOptic to JENOPTIK AG
More
09.09.2021
Gleiss Lutz advises Roche on its acquisition of the TIB Molbiol Group
More
Know-How
Know-How
11.02.2022
Non-Fungible Tokens (NFTs): Cross-border perspectives on unprecedented regulatory challenges
More
02.09.2020
The German Government’s Action Plan on Drone Regulation
More
Fields
Fields
CorporateCapital MarketsMergers and AcquisitionsPrivate EquityHealthcare and Life SciencesTMTDigital EconomyDigital Future
Mandates
Mandates
06.12.2021
Gleiss Lutz advises medical devices manufacturer Integer on its acquisition of Oscor
More
10.11.2021
Gleiss Lutz advises Coloplast on the acquisition of Atos Medical
More
21.10.2021
Gleiss Lutz advises US investor Measure 8 Ventures on financing round for Frankfurt startup Bloomwell Group
More
19.10.2021
Gleiss Lutz advises ASML on the sale of Berliner Glas Medical and SwissOptic to JENOPTIK AG
More
09.09.2021
Gleiss Lutz advises Roche on its acquisition of the TIB Molbiol Group
More
Um diese Web-App auf Ihrem Homescreen zu speichern, klicken Sie bitte auf „Zum Home-Bildschirm“
Um diese Web-App auf Ihrem Homescreen zu speichern, klicken Sie bitte auf „Zum Startbildschirm zufügen“